Article Details

For Risk-Tolerant Investors, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is Worth A Shot

Retrieved on: 2021-01-30 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

For Risk-Tolerant Investors, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is Worth A Shot. View article details on hiswai:

Excerpt

The next major institution holding the largest number of shares is Vanguard Group, Inc. (The) with 1.65 Million shares, or about 4.25% of shares ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up